FierceBiotech 2026年4月22日 Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Insilico Medicine 2026年4月21日 Insilico Medicine and Eli Lilly and Company Partner on AI-Driven Drug Discovery - CDO Magazine
BioPharma Dive 2026年4月17日 Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
BioPharma Dive 2026年4月8日 Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure
FierceBiotech 2026年4月7日 Lilly pays AC Immune $12.5M to expand Alzheimer’s collab as asset draws closer to clinic
Endpoints News 2026年4月2日 Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
Endpoints News 2026年4月2日 Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Endpoints News 2026年4月1日 Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
FierceBiotech 2026年3月31日 Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play